Three-Drug immune attack on deadly pancreatic cancer
NCT ID NCT05419479
Summary
This study is testing whether a combination of three immunotherapy drugs can help control metastatic pancreatic cancer after initial chemotherapy. The trial compares two different treatment approaches to see which works better at keeping the cancer from growing. About 46 people whose cancer has spread but responded to initial treatment will participate. The study is currently suspended and not enrolling new participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.